Enveric Biosciences, Inc. (ENVB)
1.36
-0.01
(-0.73%)
USD |
NASDAQ |
Sep 01, 16:00
1.36
0.00 (0.00%)
After-Hours: 20:00
Enveric Biosciences Cash from Operations (TTM) : -8.561M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -8.561M |
| March 31, 2026 | -8.007M |
| December 31, 2025 | -8.142M |
| September 30, 2025 | -7.668M |
| June 30, 2025 | -6.520M |
| March 31, 2025 | -7.519M |
| December 31, 2024 | -7.726M |
| September 30, 2024 | -8.166M |
| June 30, 2024 | -9.979M |
| March 31, 2024 | -11.56M |
| December 31, 2023 | -14.09M |
| September 30, 2023 | -15.81M |
| June 30, 2023 | -17.62M |
| March 31, 2023 | -17.73M |
| December 31, 2022 | -17.15M |
| September 30, 2022 | -17.75M |
| June 30, 2022 | -15.41M |
| March 31, 2022 | -12.84M |
| December 31, 2021 | -11.46M |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | -2.118M |
| June 30, 2020 | -2.224M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.363M |
| December 31, 2019 | -2.453M |
| September 30, 2019 | -2.977M |
| June 30, 2019 | -3.760M |
| March 31, 2019 | -3.090M |
| December 31, 2018 | -2.566M |
| September 30, 2018 | -2.504M |
| June 30, 2018 | -1.319M |
| March 31, 2018 | -2.362M |
| December 31, 2017 | -2.741M |
| September 30, 2017 | -1.506M |
| June 30, 2017 | -4.239M |
| March 31, 2017 | -1.976M |
| December 31, 2016 | -2.704M |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | -0.0166M |
| December 31, 2014 | -0.0432M |
| September 30, 2014 | -0.0396M |
| June 30, 2014 | -0.0461M |
| March 31, 2014 | -0.0372M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| LENZ Therapeutics, Inc. | -113.91M |
| Impact BioMedical, Inc. | -0.508M |
| ANI Pharmaceuticals, Inc. | 189.47M |
| Corcept Therapeutics, Inc. | 109.70M |
| Veru, Inc. | -26.04M |